Bohan Joseph Francis 4
4 · BIOJECT MEDICAL TECHNOLOGIES INC · Filed Jun 9, 2009
Insider Transaction Report
Form 4
Bohan Joseph Francis
Director
Transactions
- Exercise/Conversion
BJCT Common Stock
2009-06-05+18,000→ 67,000 total - Exercise/Conversion
Restricted Stock Unit
2009-06-05−18,000→ 0 totalFrom: 2009-06-05→ BJCT Common Stock (18,000 underlying)
Footnotes (3)
- [F1]50% vesting per June 5, 2008 Board Grant.
- [F2]Each Restricted Stock Unit represents a contingent right to receive one share of BJCT Common Stock.
- [F3]No expiration date.